Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 11-20 of 38 (Search time: 0.003 seconds).
previous
1
2
3
4
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib era
Grigg, A.
;
Hughes, T.
2013
Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells
White, D.
;
Eadie, L.
;
Saunders, V.
;
Hiwase, D.
;
Hughes, T.
2010
Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
Hiwase, D.
;
White, D.
;
Zrim, S.
;
Saunders, V.
;
Vaz de Melo, J.
;
Hughes, T.
2011
OCT-1 as a determinant of response to antileukemic treatment
Engler, J.
;
Hughes, T.
;
White, D.
2011
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Kantarjian, H.
;
Hochhaus, A.
;
Saglio, G.
;
de Souza, C.
;
Flinn, I.
;
Stenke, L.
;
Goh, Y.
;
Rosti, G.
;
Nakamae, H.
;
Gallagher, N.
;
Hoenekopp, A.
;
Blakesley, R.
;
Larson, R.
;
Hughes, T.
2009
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy
Hughes, T.
;
Hochhaus, A.
2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia
Giles, F.
;
DeAngelo, D.
;
Baccarani, M.
;
Deininger, M.
;
Guilhot, F.
;
Hughes, T.
;
Radich, J.
;
Ottmann, O.
;
Cortes, J.
2010
Nilotinib versus Imatinib for newly diagnosed chronic myeloid leukemia
Saglio, G.
;
Kim, D.
;
Issaragrisil, S.
;
le Coutre, P.
;
Etienne, G.
;
Lobo, C.
;
Pasquini, R.
;
Clark, R.
;
Hochhaus, A.
;
Hughes, T.
;
Gallagher, N.
;
Hoenekopp, A.
;
Haque, A.
;
Dong, M.
;
Larson, R.
;
Kantarjian, H.
2010
Dysregulation of bone remodeling by imatinib mesylate
Vandyke, K.
;
Fitter, S.
;
Dewar, A.
;
Hughes, T.
;
Zannettino, A.
2009
Impact of baseline BCR-ABL mutations on response to Nilotinib in patients with chronic myeloid leukemia in chronic phase
Hughes, T.
;
Saglio, G.
;
Branford, S.
;
Soverini, S.
;
Kim, J.
;
Muller, M.
;
Martinelli, G.
;
Cortes, J.
;
Beppu, L.
;
Gottardi, E.
;
Dongho, K.
;
Erben, P.
;
Shou, Y.
;
Haque, A.
;
Gallagher, N.
;
Radich, J.
;
Hochhaus, A.
Discover
Author
13
White, D.
11
Hochhaus, A.
9
Branford, S.
9
Radich, J.
9
Saglio, G.
8
Kantarjian, H.
7
Cortes, J.
5
Guilhot, F.
5
Kim, D.
5
Larson, R.
.
next >
Subject
34
Humans
33
Pyrimidines
29
Leukemia, Myelogenous, Chronic, B...
25
Benzamides
25
Piperazines
24
Imatinib Mesylate
20
Antineoplastic Agents
13
Fusion Proteins, bcr-abl
12
Treatment Outcome
10
Dasatinib
.
next >
Date issued
27
2010 - 2017
11
2005 - 2009